Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 4Neoplasms 4Esophageal Squamous Cell Carcinoma 3Breast Neoplasms 3Stomach Neoplasms 2Rectal Neoplasms 2Neuroendocrine Tumors 2Neoplasm Metastasis 2Glioma 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pathologic Complete Response 1Neoplastic Cells, Circulating 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Metastasis of Unknown Origin 1Lymphoma 1Lung Neoplasms 1Leukemia, T-Cell 1Leukemia 1Hypoxia 1Gynecological Tumors 1Factors Affecting BAT Activation in PET/CT 1Endometrial Neoplasms 1Distant Metastasis 1Disease 1

Interventions

Cyclophosphamide 17fludarabine 13Dexamethasone 12Cisplatin 12Rituximab 10Gemcitabine 9Paclitaxel 8Bendamustine Hydrochloride 8Lenalidomide 7Decitabine 7Cytarabine 7Carboplatin 7fludarabine phosphate 6N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 6Etoposide 6Bortezomib 6Radiotherapy 5Injections 5Azacitidine 5camrelizumab 4apatinib 4Valproic Acid 4Thalidomide 4Procarbazine 4Oxaliplatin 4Drug Therapy 4Bevacizumab 4Antilymphocyte Serum 4venetoclax 3pomalidomide 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Recurrence × Positron Emission Tomography Computed Tomography × Clear all
NCT02181192 2016-08-01

PROST-I

University of Erlangen-Nürnberg Medical School

Phase NA Unknown
180 enrolled
Genitourinary

Prostatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡